-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Inhibrx Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2023 to Q2 2025.
- Inhibrx Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2025 was -$28.7M, a 102% decline year-over-year.
- Inhibrx Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2025 was -$164M, a 110% decline year-over-year.
- Inhibrx Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $1.69B.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)